-
Greetings from Nemera!
December 22, 2017In 2018, we will keep working to improve the lives of millions of patients worldwide by designing and developing…
-
Seen in the press: Nemera Device Equivalence program on Pulmonary & Nasal Delivery magazine
December 12, 2017November 2017 issue of OnDrug Delivery Magazine, which is focused on pulmonary and nasal delivery, shows our Device…
-
Can’t wait to meet YOU at CPhI in Frankfurt!
October 17, 2017Nemera will join more than 36,000 senior pharma professionals at CPhI Worldwide, which will take place in Frankfurt, on…
-
NEMERA will be SPEAKING and exhibiting at PODD
October 13, 2017Nemera will join more than 300 key decision makers in the drug delivery, pharmaceutical and biotechnology industries during the…
-
Nemera in the press: article “Navigating the nose” about nasal delivery in The Medicine Maker
October 7, 2017In this issue of The Medicine Maker, Nemera partners with the University of Tours to investigate a new nasal…
-
Seen in the press: “Using intelligent design to deliver safe preservative-free eye drops
September 7, 2017Nemera, explains in this article, the intelligent design of multidoe bottles provides a viable means of delivering safe, preservative-free…
-
Nemera will be exhibiting and speaking at CPhI China 2017
June 15, 2017NEMERA will join over 40,000+ pharmaceutical professionals at CphI CHINA, which will take place on 20-22 June, at SNIEC,…
-
Nemera announces a research agreement with University of Tours on a new nasal administration method
June 12, 2017Research on a new nasal administration method. Nemera and the Research Center for Respiratory Diseases (CEPR) of Tours University…
-
Nemera will be exhibitor and speaker at SMI Pre-filled syringes West Coast !
May 30, 2017Nemera will be exhibiting and speaking at SMi Group’s 4th annual Pre-Filled Syringes West Coast conference, which will take…
-
Nemera will be exhibiting and presenting a poster at ARVO 2017!
April 28, 2017Nemera will join the leaders in eye and vision research from around the world at next ARVO, which will…